Phase 4
Completed N=70
Telephone Based Management of Hyperlipidemia
Source: ClinicalTrials.gov NCT01212159 ↗Enrolled (actual)
70
Serious AEs
2.9%
Results posted
Sep 2015
Primary outcomePrimary: LDL Level Change From Baseline — -63.4; -54.6 mg/dl — p=0.391
Summary
The purpose of the study is to demonstrate that systematic self measurement of blood lipids reduces LDL cholesterol more effectively than standard care. The hypothesis is that cholesterol lowering medication adherence will be improved with self monitoring and reporting of frequent blood lipids and the percentage of patients achieving LDL goal will be greater than without home monitoring.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY LDL Level Change From Baseline |
-63.4; -54.6 | 0.391 |
| SECONDARY Medication Compliance |
2.4; 2.4 | — |
| SECONDARY LDL Values at Two Week Interval |
96.3; 92.4; 118.6 | — |
Eligibility Criteria
Inclusion Criteria
- LDL > 130mg/dl
Exclusion Criteria
- Pregnant patients
- liver disease
- allergic reaction to statins
Data sourced from ClinicalTrials.gov (NCT01212159). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.